PDS BIOTECHNOLOGY CORP
2.1700
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.0800
+3.83%
Today's range
2.1200 - 2.2400
ISIN
N/A
Source
NASDAQ
-
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
02 May 2024 08:00:00 By Nasdaq GlobeNewswire
-
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
27 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
20 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
22 Jan 2024 16:45:19 By Nasdaq GlobeNewswire
-
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
16 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04 Dec 2023 16:50:00 By Nasdaq GlobeNewswire
-
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
28 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
14 Nov 2023 07:30:55 By Nasdaq GlobeNewswire
-
PDS Biotechnology Announces Conference Call and Webcast for Third Quarter 2023 Financial Results
07 Nov 2023 08:00:01 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
02 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
PDS Biotech to Present at the LD Micro Main Event XVI
26 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
25 Sep 2023 08:00:13 By Nasdaq GlobeNewswire
-
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
20 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
-
20 Sep 2023 08:00:18 By Nasdaq GlobeNewswire